Crelosidenib
Crelosidenib is an investigational new drug that is being evaluated for the treatment of cancer.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Crelosidenib is an investigational new drug that is being evaluated for the treatment of cancer. It acts as a selective inhibitor of isocitrate dehydrogenase 1 (IDH1), an enzyme that plays a crucial role in cellular metabolism and is frequently mutated in various cancers, including cholangiocarcinoma.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1329432813 under CC BY-SA 4.0; modifications have been made.